Technology Transfer in the Pharmaceutical Industry
Technology Transfer In Phamra

Technology Transfer in the Pharmaceutical Industry

Technology transfer is critical in any drug development program, occurring for various reasons and at different development stages.

A sponsor based in South Africa, Latin America, Algeria, Iraq, etc. may be looking for contract development and manufacturing organization (CDMO) like JoinHub Pharma for clinical trial manufacturing; to transfer a manufacturing process to a larger, commercial-scale CDMO; or to replace a CDMO that has quality issues.

The handling of a technology transfer can significantly impact the success of a product’s development and, ultimately, its commercial manufacturing.

In this blog, we will cover everything you need to know about the technology transfer process in the pharmaceutical industry.

What is Technology Transfer???

Technology Transfer is simply a “logical approach that regulates the transfer of any process along with its documentation and professional expertise between developments or pharma manufacture facilities.”

In the pharmaceutical industry, “Technology transfer ” is known as the process of successful improvement from drug discovery to product development, clinical trials, and eventually full-scale commercialization.

Technology transfer is beneficial to develop dosage forms in various ways. It delivers efficiency in the process, maintains the product quality, and helps achieve a standardized approach, facilitating cost-effective production. It is how an original innovator of technology makes its technology available to commercial partners that exploit it.

Technology transfer is vital for such researchers to materialize on a larger scale for commercialization, particularly in the case of developing a pharma product. Technology transfer includes patentable aspects of production and consists of the business processes such as knowledge and skills.

Reasons for the Adoption of Technology Transfer

  • Regulatory Landscape
    • Some strict laws and regulations block the market in developing countries, mainly for foreign corporations. These laws protect local production in their own countries, especially drug manufacturing, making technology transfer for all foreign corporations a more feasible option.


  • Competitive Pricing
    • Transferring technology to local pharma manufacturers in developing countries such as Algeria, Iraq, Honduras, Guatemala, etc., leads to more affordable production and labor costs, thereby lowering the cost of pharma medicine manufacturing and increasing margins.


  • Increase in Manufacturing Capacity
    • Pharma companies’ manufacturing capacity can potentially increase by 2x to 3x, eventually leading to actual savings of 30-40% in production cost over one to four years. JoinHub Pharma – A leading Indian Pharmaceutical Company, has been offering technology transfer to pharma companies worldwide and helping them gain savings using a WHO-GMP certified manufacturing facility in Gujarat, India.

How JoinHub Pharma Helps you with Technology Transfer

As a leading pharmaceutical company in India, we help our partners across the world to grow their pharma business with several documents to ensure a successful technology transfer:

Successful Process Transfer begins with an Assessment of the Product’s Technical Package

A detailed assessment of the technical package is completed to understand the scale and equipment differences in the planning stage. JoinHub Pharma’s Technical Team includes technical services, manufacturing, and engineering teams, perform process verification activities from small feasibility studies, small-scale, and scale-up verification runs to optimize the pharma manufacturing process and establish a successful product transfer.

Protocols are designed to determine the study plans, and data is collected to support technical reports, submission batch production, and regulatory submissions and licenses.

Detailed Analytical Methods

Analytical processes are one of the very first elements of a manufacturing process to be transferred. They are additionally the foundation of technology transfer success since the results of the analyses are utilized for comparability assessments.

Standardized Tech Transfer Procedures

Being a leading pharma contract manufacturer, we are very flexible to accommodate various client needs. A standardized tech transfer method and common language are specified to improve the tech transfer process.

Knowledge Transfer Package and Transfer Planning

We provide a detailed and complete knowledge transfer package as possible with product information such as:

  • raw materials
  • analytical methods
  • validation reports
  • manufacturing procedures
  • process parameters
  • equipment requirements
  • regulatory requirements, etc.

These are the technology transfer packages, and we perform a thorough assessment and preparation to support the knowledge transfer process.

The Project Manager creates a transfer plan with the help of Subject Matter Experts (SMEs). The plan is agreed upon and executed by all the functional teams, and a kick-off meeting is arranged to ensure the team is aligned with the scope, strategy, and overall deadline.

Product Launch Preparation

As a top contract manufacturer, we have a defined process for product launch so that the team can be ready for commercial supply to support the product launch.

The defined process also has a flexible and adaptable mechanism to accommodate the early or delayed approval to support the product supply for various markets following different agency policies.

Technical Gap Analysis

This is a formal documentation of the assessment of known and potential gaps between the donor and receiving sites’ capabilities and their readiness for the transfer.

For instance, the analysis will decide if the receiving site has the right equipment in place to perform the transferred manufacturing process or analytical techniques. The document will also include a risk assessment.

Adequate Change Control Management System

Any changes or adjustments made to the process or equipment should be documented, assessed, and justified regarding their potential impact on the CQAs and the Quality Target Product Profile (QTPP).

Major Benefits for Pharma Companies

Based on our collaboration so far, this digitalization of technology transfer will help save pharma and biotech companies approximately $10-15 million for each product, eliminate the verification and qualification processes and batches by almost 50%, reduce the average technology transfer process to 6 months (rather than 20 months), and eliminate many pilot and engineering batches – as well as destroy several cycles of laboratory work related to those batches.

By integrating the solution with pharma manufacturers’ other systems, every organization and every function involved can directly steer quality in real-time throughout the production process. Careful change management is required to ensure the adoption of this new way of working along the journey from R&D to commercialization.


Several small pharma companies have rapidly adopted technology transfer in the last few years since it allows them to break into untapped markets while providing an opportunity for aggressive pricing.

Proper communication between the licenser and the licensee plays a significant role in a successful technology transfer process. A detailed and transparent contract between the two pharma companies is necessary for a successful collaboration where both the companies can grow.

JoinHub Pharma’s experts understand your varying compound needs, dosage form, or project and ensure optimal performance within your timeline and budget.

Our in-house CMC (chemistry, manufacturing, and controls) professionals can advise on formulation and design, manage site inspection and monitoring, design and review protocols, identify the most suitable validation strategy for FDA and other compliance, and provide invaluable strategic insights for manufacturing scale-up.

Looking for a reputed pharmaceutical company for Technology transfer in South Africa, Algeria, Iraq, Nigeria, Latin America, and CIS countries? Look no further than the best pharma technology transfer partner – JoinHub Pharma.

Contact us to learn how we can help your small pharmaceutical company grow across the world.

generic Indian drugs
Generic Medicine

How COVID-19 Open up Opportunities for India’s Pharma Industry that Must Be Seized

Given the magnitude of the COVID pandemic and its spread across the world, it seems to be almost certain by now how a post-coronavirus world will observe an altogether different ordering of the worldwide economic and political system of commitments and preferences.

If the Great Recession of 2008 united numerous nations in guaranteeing collective banking and financial sector reforms – to save an infectious spread in the financial sector – the 2020 worldwide pandemic shall ideally make the global commitments and needs of most nations more skewed towards guaranteeing more prominent public health security for its citizenry.

Up until this point, as the crisis is still unfolding, many critical multilateral arrangements in place – regardless of whether the G20 or G7 – have played a limited role in introducing a unified front or in reassuring and giving effective measures of relief to most affected nations.

The G2 ‘Great Powers Club’ too for example US and China, have confronted criticism for showing weak global leadership, as the pandemic has infected one country after another.


But what about India?

In comparison to other countries, say, China, Eurozone, or the United States, India has been both fortunate and cautious, in preventing the infectious spread of the virus in its domestic territory with early restrictions on mobility from different countries, seeking contact tracing, and declaring a lockdown early. It has likewise taken larger efforts as of late to send across medical supplies and drugs to different countries in need.

Assuming that the country takes all the important precautions ahead and keeps the infection curve trajectory more flattened, India has a decent opportunity to come out on the better side of the crisis. What’s more, that offers India a window of opportunity in this emergency.

So, how would India be able to utilize this crisis as an opportunity to reorder its own worldwide commitments and rise as a significant actor to permit more nations to become interdependent and associate with a huge developing market?

In a post-coronavirus global order, India’s similar favorable position can depend intensely on becoming a significant provider for global public goods and services, given how the demand for these are probably going to go up in years to come.

Here, we talk about the prospects in healthcare as a case in point.

India’s current preferred position of large-scale pharmaceutical production enables it to significantly leverage its soft power by investing in the outward growth of the healthcare sectors of different nations by:

  • Ramping up exports in drugs;
  • Turning into a preferred medical tourist destination for those looking for affordable treatment in quality secondary/tertiary health services,
  • Seek after medical diplomacy by offering medical training and technical expertise to many other developing nations whose healthcare systems are a lot worse than India.


Boosting pharma exports

As per the Indian Brand Equity Foundation (IBEF), pharmaceutical exports of India from the financial year 2012 to 2019 have consistently grown from $10 billion to $19 billion.

According to estimates, India represents about 10% of the world’s pharmaceutical production by volume and 1.5% by value. The industry is the world’s biggest supplier of generic drugs and controls around 18% of the worldwide market. It is additionally a leading producer of vaccines on the planet and caters to about 50% of worldwide vaccine demands.

This is because of the effective high demand for Indian drugs in light of cheaper pricing, making these more reasonable to both developing and developed nations.

Indeed, even with the breakout of the COVID-19 pandemic, many private Indian pharma manufacturers expressed their desire to expand their supply of required medications to these nations.

Not only states, however public health non-state actors and many international NGOs have been utilizing generic Indian drugs for affordable treatment in countries within Africa, parts of Latin America over the last decade.


Empowering medical tourism in India

Over the last few years, especially since 2014, the number of people coming to India for medical treatment has grown yearly at about 55%. As per the Ministry of Tourism, the medical tourism space was estimated at around $3 billion (US$) in 2015 and at $9 billion in 2020.

The Indian government has additionally advertised India as a superior medical tourist destination by giving fast-track medical visas and rapid airport clearances for those visiting as medical tourists. Although, most vital players in the medical tourism space are those in the private sector yet obviously it is clear that this is a space for the Indian government to develop significantly more capacity in years ahead.


Pursue medical diplomacy

In spite of India’s colossal steps in medical-value tourism and in the growth of pharmaceutical exports, it actually has a long road ahead to use its potential at a worldwide level. India’s own public-healthcare system appears in poor shape (excepting some of the states in the Southern and North-Eastern part of the nation). It has one of the most minimal doctor-to-population ratios in the world. The gains accrued have to a great extent been due to the asymmetric, privatized nature of the healthcare system in India-which has permitted the private sector to make inroads to other local/and global accomplices (in West Asia).

To project itself as a nation practicing medical diplomacy through soft-power, if there is one nation from which the Indian state can especially learn, is Cuba.

Regardless of being a small nation with a much lower per-capita income, Cuba’s public healthcare system is truly outstanding in the world. The Cuban State has polished a humanitarian goal of medical-internalization as a major aspect of its diplomatic mission and acquired a more extensive reputation and praise by offering doctors and medicines at times of health-emergencies in many nations in need. Its medical teams -sent in the state, have likewise maintained a longer presence in health emergencies prone areas around the globe with around 50000 doctors stationed abroad by 2018. In the recent past too, Cuba sent the biggest group of medical doctors to West Africa during the Ebola epidemic.

The communist state additionally embraced a diplomatic strategy of making bilateral agreements with countries like Argentina and Venezuela, to pay for offered medical services, while likewise guaranteeing medical aid to nations like Algeria and Haiti in times of war and different crises. Thus, this arrangement by the year 2018 brought about $11 billion in (medical) exports from Cuba while additionally financing its helpful efforts.

In a post-coronavirus world, healthcare would rise as a significant point of attention for some countries over the world. What’s more, in a reordered version of globalization, worldwide public goods like healthcare security will attract countries to look for partners with a more comparative advantage in providing for medical expertise for treatment, essential medications; and in-state capacity-building for medical-aid and service to different countries (as needed).

India can possibly do tremendously well in the first two of these areas (given its similar advantages in pharma-based exports and in medical tourism), for the third, in embedding state-diplomacy with medical-diplomacy and putting resources into its outreach, there should be a radical (re)orientation in our worldwide (diplomatic) priorities and duties, starting from territorial to international channels.

We at JoinHub Pharma – the leading pharmaceutical company in India manufacture high-quality, affordable branded and generic medicines. Contact us to discuss more pharma products.


Call: +91 9979382527
Mail us at [email protected]

pharmaceutical company in India
Pharmaceutical Company

The Leading Pharmaceutical Company in India to Provide a Range of Medications and Additional Services

The WHO GMP certified companies in India are working continuously towards enhancement of the affordability of the medicines by investing in the manufacturing capital that facilitates the point of C GMP compliance as well as global approval.

Over the years, the team members had built confidence and now there has been a constant as well as timely delivery of dependable products. The manufacturers are continuously striving for retaining the standards by manufacturing high-quality medicines that also take into consideration the implementation of the innovative as well as the path-breaking technologies for delivery of the superior quality products. They always use stringent practices for the generic medicine export from India. Presently, there are plenty of products that fall under the category of generic medicine export from India along with the therapeutic category. Besides, the licensed facilities that support both the generic as well as the biotic business makes them stand out. There has been a better development of the new drug delivery with the facilitation of the infrastructure that supports the API as well as the formulation of the development and strengthening of the platform technologies.

A highlight on Joinhub Pharma

Over the years, the company’s Joinhub Pharma has been working on the achievement of high-quality standards in the pharmaceutical industry. There is a quality management system that adheres to the scientific solutions with the use of innovative products designed for the improvement of quality of life. The fully integrated pharmaceutical company is striving for providing the list of medications available at affordable prices.

The aspiring pharmaceutical company now excels in the selling of analgesics, anti-infectives, antibiotics, Critical Care antibiotics, nutritional products, antioxidants, protein powders, Gastro medicines, and everything else. So, there is the sourcing of reliable products from reliable vendors who ensure that their clients are getting the best quality products. Besides, there are also options for the customers to avail of the range of the comparatively low priced medicines.

What makes the services stand out?

  • The team of experts always pays attention to quality for remaining on the top of the priority list that makes them offer high standard products to the consumers.
  • The workers always pay attention to the timely delivery of your order. So, you can rest assured that they will be delivering it at the needed time.
  • With the wide range of products that will be getting from the teams, you can rest assured that there are a variety of illnesses that can be solved with them.
  • The largest pharmaceutical manufacturing company is now having the qualified as well as experience team for taking care of the manufacturing and supplying of all kinds of tablets, capsules, syrups, ointments, dry syrup, as well as the herbal medicine.
  • The company also implies to the requirements laid down by the schedule M GMP of the drugs and cosmetics act. Overall, there is a constant focus on the quality standards for the maintenance of the record check.
  • They are always committed to providing excellence. They always undertake strategies for the improvement of the products in every possible manner. They always find the rights quotes for the improvement and achievement of their objective.
  • The team also comprises of the highly qualified teams of experts and scientists who work together throughout the research and development activities. The team always takes into consideration finding better alternatives for the development of the expensive and less feasible product.
  • They also take special care in the estimation of the quality of maternal health care products. In addition to that, they strive for enhancing the experience and keep working on the transformative solutions for the secured will being.

Newness in the pharmaceutical field

The pharmaceutical company, Joinhub Pharma is one of the top generic pharma companies in India and develops the indispensable tool that is helping them to move forward in terms of the manufacturing of the new medical standards. Besides, the RND Laboratories along with the Clinical Research organizations are ensuring that they stand ahead in terms of the discovery of the immunoassay kits, reagents, systems, as well as customer services. Besides, they make use of the technology standards for enabling the precise measurement of the molecules at every level for the development of the biomarker. The scientists have familiarity with additional immunoassays that also works with the combination of a traditional workflow with patented technology.

A responsible group of professionals

Joinhub Pharma, the Indian pharmaceutical company is spanning as a network of the facilities that are seeking the expansion of the vision both horizontally as well as vertically. Besides, the pharmaceutical company in India units is also setting compliance with environmental hazards based norms. The pollution-free company is now taking responsibility for developing a good network of pharmaceutical companies in India in a better way. It makes use of the state-of-the-art missionary as well as equipment. Overall, there is the friendly best pharmaceutical manufacturing unit that is spanning in the domestic market. The leading pharmaceutical company is now placed in terms of offering the largest portfolio of the effective as well as safe generic products that can cover the major therapeutic categories.

Call : +91 9979382527
Mail us at [email protected]